FDA warns against counterfeit Botox sold online
U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles, reports BritPanorama.
The Food and Drug Administration (FDA) indicated it is taking action following reports of injuries linked to these products, including serious toxic side effects. Botulinum toxin, the active ingredient in Botox, is among the most toxic substances known and functions by temporarily blocking nerve signals to relax muscles. While primarily approved for cosmetic treatments, Botox is also sanctioned for various medical ailments, including muscle spasms, eye disorders, and migraines.
The FDA’s warnings predominantly targeted cosmetic websites. In these instances, the agency disclosed that the companies were offering unofficial or mislabeled versions of Botox-like drugs that had not received approval. Since Allergan introduced the original Botox in 1989, the FDA has also authorized several competing formulations.
The FDA-approved Botox products carry the agency’s most severe warnings, including boxed labels that inform doctors and patients of potential serious or life-threatening side effects. In rare occurrences, the toxin can disseminate beyond the injection site, leading to paralysis or muscle weakness necessary for respiration and swallowing. Symptoms of botulism can develop hours after an injection and include difficulties with swallowing or breathing, slurred speech, and muscle weakness.
On Wednesday, the FDA reiterated its advice for patients to obtain these drugs solely from health professionals who are properly licensed and trained. It stressed the importance of seeking immediate medical attention for anyone experiencing signs of botulism.
This latest move highlights ongoing concerns about the safety of cosmetic treatments available online and the need for vigilance in consumer health.
